nifedipine has been researched along with granisetron in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Sen, S; Sinha, N | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jaup, EA; Jodal, M; Lundgren, O; Timar Peregrin, A | 1 |
| Ahlman, H; Jodal, M; Lundgren, O; Svensson, M; Timar Peregrin, A | 1 |
| Ahlman, H; Jodal, M; Lundgren, O; Peregrin, AT | 1 |
| Jodal, M; Lundgren, O; Sörensson, J | 1 |
| Coboeken, K; Dallmann, A; Eissing, T; Hempel, G; Ince, I | 1 |
1 review(s) available for nifedipine and granisetron
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for nifedipine and granisetron
| Article | Year |
|---|---|
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Nervous control of alkaline secretion in the duodenum as studied by the use of cholera toxin in the anaesthetized rat.
Topics: Alkalies; Anesthesia; Anesthetics, Local; Animals; Atropine; Calcium Channel Blockers; Cholera Toxin; Duodenum; Granisetron; Hexamethonium; Lidocaine; Male; Muscarinic Antagonists; Myenteric Plexus; Nicotinic Antagonists; Nifedipine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists | 1998 |
The effects on net fluid transport of noxious stimulation of jejunal mucosa in anaesthetized rats.
Topics: Anesthesia; Animals; Atropine; Axons; Calcium Channel Blockers; Calcium Channels; Capsaicin; Enteric Nervous System; Enterochromaffin Cells; Glucose; Granisetron; Hexamethonium; Hydrochloric Acid; Hydrogen-Ion Concentration; Hydroxyindoleacetic Acid; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Muscarinic Antagonists; Nicotinic Antagonists; Nifedipine; Organ Preservation Solutions; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Stimulation, Chemical; Tromethamine; Water | 1999 |
Involvement of serotonin and calcium channels in the intestinal fluid secretion evoked by bile salt and cholera toxin.
Topics: Animals; Bile Acids and Salts; Calcium Channels; Cholera Toxin; Felodipine; Granisetron; Intestinal Mucosa; Male; Nifedipine; Rats; Rats, Sprague-Dawley; Serotonin | 1999 |
Involvement of nerves and calcium channels in the intestinal response to Clostridium difficile toxin A: an experimental study in rats in vivo.
Topics: Animals; Bacterial Toxins; Calcium Channel Blockers; Calcium Channels; Clostridioides difficile; Coloring Agents; Erythrocyte Volume; Evans Blue; Granisetron; Hexamethonium; Intestine, Small; Male; Nicotinic Antagonists; Nifedipine; Peroxidase; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Statistics, Nonparametric | 2001 |
A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.
Topics: Caffeine; Cytochrome P-450 Enzyme System; Diazepam; Female; Granisetron; Humans; Metoprolol; Metronidazole; Midazolam; Models, Biological; Nifedipine; Ondansetron; Pharmaceutical Preparations; Pregnancy | 2018 |